XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Operating expenses        
General and administrative $ 2,790 $ 2,883 $ 5,399 $ 6,200
Research and development 9,729 11,307 18,413 23,373
Total operating expenses 12,519 14,190 23,812 29,573
Operating loss (12,519) (14,190) (23,812) (29,573)
Other income        
Grant income 0 0 0 25
Research and development incentive income 472 750 1,064 1,483
Interest income, net 1,756 1,465 3,764 2,733
Other financing expense 0 (964) 0 (964)
Foreign exchange gain (loss) (150) (118) 7 247
Total other income, net 2,078 1,133 4,835 3,524
Net loss before provision for income taxes (10,441) (13,057) (18,977) (26,049)
Income tax expense, current (105) (50) (191) (30)
Net loss and comprehensive loss $ (10,546) $ (13,107) $ (19,168) $ (26,079)
Net Loss per share        
Net Loss per share, Basic $ (0.13) $ (0.17) $ (0.23) $ (0.33)
Net Loss per share, Diluted $ (0.13) $ (0.17) $ (0.23) $ (0.33)
Weighted average number of shares outstanding        
Weighted average number of shares outstanding, Basic 82,464,226 78,304,363 82,269,965 78,138,940
Weighted average number of shares outstanding, Diluted 82,464,226 78,304,363 82,269,965 78,138,940